Pharmacological management of migraine (SIGN)

This toolkit summarises the evidence-based recommendations in SIGN 155: Pharmacological management of patients with migraine. For the full guideline see

Evidence-based recommendations are identified using an Recommendation.

Recommended best practice based on the clinical experience of the guideline development group, are denoted by Good practice point tick